Page 7 - Evidence Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Population-level screening for cardiovascular disease (CVD) risk factors has no effect on lowering CVD morbidity and mortality, concludes a recently published WHO Health Evidence Network (HEN) report. To reduce CVD risks, which are also associated with poorer COVID-19 outcomes, the report proposes some alternative measures for consideration by policy-makers in the WHO European Region.

Reply The study — the largest of its kind — examined a group of more than 1.1 million patients in the United States and Spain using antihypertensives. (Shutterstock) LOS ANGELES, CA — An international research team co-led by a UCLA Fielding School of Public Health professor found that two widely used types of blood pressure drugs are not tied to an increased risk of COVID-19 infection or complications. The study — the largest of its kind — examined a group of more than 1.1 million patients in the United States and Spain using antihypertensives, according to Dr. Marc Suchard, a profe...

If the coronavirus pandemic and Europe-wide lockdowns taught us one thing, it is just how reliant we all are on digital technologies – including for our own health, and that data was in the right place at the right time to answer the right questions. Nigel Hughes is Scientific Director at Jannsen Research and Development (Johnson & Johnson), a Corporate Knowledge Partner of All Policies for a Healthy Europe.  Digital health can have a transformational impact on the well-being of EU citizens: from telemedicine enabling safe remote treatment of patients, to health data access allowing tracki...